Back to Results
First PageMeta Content
Health / Anakinra / Rheumatoid arthritis / Etanercept / Disease-modifying antirheumatic drug / Adalimumab / Infliximab / Rheumatology / Leflunomide / Medicine / Immunosuppressants / Pharmacology


Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Add to Reading List

Document Date: 2009-10-02 10:13:41

Open Document

File Size: 854,56 KB

Share Result on Facebook

City

Houston / Malvern / Minneapolis / Ottawa / Frederiksberg / /

Company

AMSTAR / AEs / Sharp / SAS Institute Inc. / John Wiley & Sons Ltd. / Cochrane Musculoskeletal Group / Microsoft / /

Continent

Europe / /

Country

United States / Canada / Australia / Denmark / /

/

Event

Product Issues / FDA Phase / /

Facility

Minneapolis VA Medical Center / Parker Institute / University of Ottawa / American College / Institute of Population Health / Frederiksberg Hospital / University of Ottawa Heart Institute / The Cochrane Library / University of Texas / Monash University / Cabrini Hospital / Anderson Cancer Center / /

IndustryTerm

search term / Search methods / literature search / /

MedicalCondition

lymphoma / tumor necrosis factor-alpha / systemic inflammatory disease / rheumatoid arthritis / RA disease / systemic and joint inflammation / inflammatory cytokines / least moderate disease / infections / low disease / condition Rheumatoid arthritis / Cancer / disease / upper respiratory infection / pain / tumor necrosis / infection / inflammation / serious infection / /

MedicalTreatment

biologic therapy / cell therapy / /

Movie

Quality of Life / /

Organization

Centre for Global Health / Cabrini Hospital / European League Against Rheumatism / Eta / University of Ottawa / Parker Institute / Cardiovascular Research Reference Centre / Monash University / American College of Rheumatology Classification / Ottawa Heart Institute / Department of Epidemiology and Preventive Medicine / Institute of Population Health / European Medicines Agency / Frederiksberg Hospital / Musculoskeletal Statistics Unit / U.S. Food and Drug Administration / EMEA / Minneapolis VA Medical Center / FDA / Monash Department of Clinical Epidemiology / University of Texas / /

Person

Maria Angeles / Elizabeth Tanjong / /

Position

General / author / physician global assessments / Major / /

Product

HUMIRA / DMARDs / leflunomide / RITUXAN / cyclosporine / sulfasalazine / REMICADE / ORENCIA / KINERET / ENBREL / I2 / USA / response / /

ProvinceOrState

Texas / Minnesota / /

Technology

alpha / cell therapy / /

URL

http /

SocialTag